Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127560061 | 12756006 | 1 | I | 20160909 | 20160916 | 20160916 | EXP | US-ASTRAZENECA-2016SE96974 | ASTRAZENECA | 70.00 | YR | F | Y | 0.00000 | 20160916 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127560061 | 12756006 | 1 | PS | FASLODEX | FULVESTRANT | 1 | Intramuscular | U | 21344 | 500 | MG | INJECTION | |||||||
| 127560061 | 12756006 | 2 | SS | LISINOPRIL. | LISINOPRIL | 1 | Oral | U | 0 | 10 | MG | TABLET | QD | ||||||
| 127560061 | 12756006 | 3 | C | IBRANCE | PALBOCICLIB | 1 | Oral | 0 | 125 | MG | CAPSULE | QD | |||||||
| 127560061 | 12756006 | 4 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | Oral | AS NEEDED | 0 | 10 | MG | TABLET | QD | ||||||
| 127560061 | 12756006 | 5 | C | DILACOR | 2 | Oral | 0 | TABLET | |||||||||||
| 127560061 | 12756006 | 6 | C | MACROBID | NITROFURANTOINNITROFURANTOIN MONOHYDRATE | 1 | Oral | 0 | 50 | MG | CAPSULE | BID | |||||||
| 127560061 | 12756006 | 7 | C | PERCOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | Oral | 5-325 MG, EVERY 4-5 HOURS AS NEEDED | 0 | TABLET | |||||||||
| 127560061 | 12756006 | 8 | C | PROZAC | FLUOXETINE HYDROCHLORIDE | 1 | Oral | 0 | 20 | MG | CAPSULE | QD | |||||||
| 127560061 | 12756006 | 9 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 0 | 20 | MG | TABLET | QD | |||||||
| 127560061 | 12756006 | 10 | C | TRAMADOL. | TRAMADOL | 1 | Oral | AS NEEDED | 0 | 50 | MG | TABLET | Q4H |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127560061 | 12756006 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127560061 | 12756006 | Back pain | |
| 127560061 | 12756006 | Breast cancer | |
| 127560061 | 12756006 | Disease progression | |
| 127560061 | 12756006 | Fatigue | |
| 127560061 | 12756006 | Hot flush | |
| 127560061 | 12756006 | Metastases to bone | |
| 127560061 | 12756006 | Metastases to liver | |
| 127560061 | 12756006 | Metastases to spine | |
| 127560061 | 12756006 | Myalgia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127560061 | 12756006 | 1 | 201411 | 0 | ||
| 127560061 | 12756006 | 3 | 20160622 | 0 | ||
| 127560061 | 12756006 | 6 | 20160128 | 0 | ||
| 127560061 | 12756006 | 7 | 20160822 | 20160830 | 0 | |
| 127560061 | 12756006 | 10 | 20160727 | 0 |